Targeting only cytochrome bc1-aa3 oxidase or NDH-2 might be most valuable for the treatment of infections caused by mycobacteria, such as M. leprae, that do not possess a functional cytochrome bd oxidase or NDH-1. Here, DHX9 is linked to infection.